SOF-SKN manufacturing begins to ensure clinical trial readi
other announcement
Latest articles and price-sensitive announcements with AI sentiment classification.
other announcement
Highlights Noxopharm expands focus on next-generation cancer immunotherapy Sofra platform draws attention with fresh immune activation findings Immuno-oncology momentum continues across global biotech markets Noxopharm has re-entered market focus after unveiling fresh Sofra platform findings linked to cancer immunotherapy research, highlighting broader interest in innovative immune-based treatment technologies. Cancer immunotherapy continues reshaping the global biotechnology landscape,...

Noxopharm (ASX:NOX) shares Skyrocket 40% Today- Here’s Why? Kalkine
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
director_dealing announcement
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement